This is the third note in a row about cholesterol, but that's because it has been featured so much recently in the mainstream media and academic publications.
The headline in the UK
Times newspaper on January 14th, 2020 was "New cholesterol 'vaccine' could save thousands of lives a year" (Ref 1). The BBC headline was "NHS to pioneer cholesterol-busting jab" (Ref 2). The BMJ reported: "Inclisiran: UK to roll out new cholesterol lowering drug from next year" (Ref 3).
The media story may have been a UK one, but the drug that it featured is very much a global phenomenon. The coverage was also interesting because it wasn't the result of a press release about findings from a research trial, which is normally the case. It was a PR/marketing story about a "novel partnership" between the pharmaceutical company, Novartis, and the UK National Health Service "which will see patients receive accelerated access to its groundbreaking cholesterol-lowering drug inclisiran" (Ref 4).
Comment: See also: "One of the most valuable medicines we possess": The Victorian doctor who promoted medical cannabis
And check out SOTT radio's: The Health & Wellness Show: The Highs and Lows of Cannabis as Medicine